Primer: Biogen Inc (BIIB US) - Aug 2026
Biogen is in a pivotal transition, shifting its reliance from a maturing Multiple Sclerosis (MS) franchise to a new growth portfolio focused on...
91 Views
Primer: Biogen (BIIB UW) - Sep 2025
Biogen is in a pivotal transition phase, shifting from its declining, legacy multiple sclerosis (MS) franchise to a new portfolio focused on...
110 Views